MIRA INFORM REPORT

 

 

Report Date :

27.11.2014

 

IDENTIFICATION DETAILS

 

Name :

PULSE PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

4F 10, 5th Floor, Ballad Estates, Taranaka, Secunderabad – 500017, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

09.01.1997

 

 

Com. Reg. No.:

01-026151

 

 

Capital Investment / Paid-up Capital :

Rs.46.492 Millions

 

 

CIN No.:

[Company Identification No.]

U24239AP1997PTC026151

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

No. of Employees :

500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (42)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 534000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company satisfactory track record.

 

There seems some continuous dip in the profit of the company however, net worth of the company is satisfactory. General financial position of the company is normal and acceptable for business dealings.

 

Tarde relations are reported as fair. Business is active. Payments terms are reported to be slow but correct.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long-Term Rating BB+

Rating Explanation

Moderate risk of default.

Date

March 3rd  2014

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Suresh

Designation :

Hon Director

Contact No.:

91-9346155755

Date :

26.11.2014

 

 

LOCATIONS

 

Registered Office :

4F 10, 5th Floor, Ballad Estates, Taranaka, Secunderabad – 500017, Andhra Pradesh, India

Tel. No. :

91-40-27007049

Mobile No. :

91-9346155755 (Mr. Suresh)

Fax No. :

91-40-27014274

E-Mail :

ampulse_2004@yahoo.com

suresh@pulespharma.net

askus@pulsepharma.net

Website :

www.pulespharma.net

 

 

Factory :

Khasra No. 400, 407, 409, Karondi, Roorkee, - 247667, Uttarakhand, India

Tel. No. :

91-1332-232125

Fax No. :

91-1332-232126

 

 

R and D Centre :

Plot No. 28/1/11, B/C Road, No. 15, IDA, Nacharam, Hyderabad, Andhra Pradesh, India

Tel. No. :

91-40-27007049

Fax No. :

91-40-27014274

 

 

DIRECTORS

 

As on 30.09.2013

 

Name :

Pushpa Mittra Bhargava

Designation :

Director

Address :

12-5-27, Vijayapuri, Tarnaka, Hyderabad - 500017, Andhra Pradesh, India

Date of Birth/Age :

2.22.1928

Date of Appointment :

30.09.2013

DIN No. :

00057140

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

L24110TG1993PLC016112

AVON ORGANICS LTD

Director

31/01/03

31/01/03

01/08/09

Active

NO

2

U24232TG2007PTC052358

VRINDA LIFE SCIENCES PRIVATE LIMITED

Additional director

22/01/10

22/01/10

-

Active

NO

3

U73100TG2010PTC067765

EDB LIFE SCIENCES INDIA PRIVATE LIMITED

Director

31/03/10

31/03/10

-

Active

NO

4

U73200TG2004NPL043436

GENOME FOUNDATION

Director

01/08/12

01/08/12

-

Active

NO

5

U24239AP1997PTC026151

PULSE PHARMACEUTICALS PRIVATE LIMITED

Director

30/09/13

01/10/12

-

Active

NO

 

 

Name :

Venkat Ram Babu Katragadda

Designation :

Director

Address :

206, Divya Enclave, Vijayapuri, Taranaka, Secunderabad - 500017, Andhra Pradesh, India

Date of Birth/Age :

07.01.1965

Date of Appointment :

09.01.1997

DIN No. :

00300647

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239AP1997PTC026151

PULSE PHARMACEUTICALS PRIVATE LIMITED

Director

09/01/97

09/01/97

-

Active

NO

2

U70102TG2008PLC061677

LORVEN INFRA PROJECTS (INDIA) LIMITED

Director

04/11/08

04/11/08

10/11/08

Active

NO

3

U24232TG2010PTC068144

ZENOVA BIO NUTRITION PRIVATE LIMITED

Managing director

27/05/10

28/04/10

-

Active

NO

4

U24233TG2010PTC071007

VIVO LIFE SCIENCES PRIVATE LIMITED

Managing director

24/02/11

28/10/10

-

Active

NO

5

U24232TG2011PTC074902

NANOCEUTICA LABORATORIES PRIVATE LIMITED

Director

09/06/11

09/06/11

-

Active

NO

 

 

Name :

Katragadda Radhika

Designation :

Director

Address :

H. No.12-5-34, Flat No.206, Divya Homes, Vijayapuri, Taranaka, Secunderabad - 500017, Andhra Pradesh, India

Date of Birth/Age :

23.08.1971

Date of Appointment :

09.01.2001

DIN No. :

00587365

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2013

 

Names of Shareholders

No. of Shares

%age

K. V. Raambabu

3246719

69.83

K. Suresh Babu

68750

1.48

K. Radhika

1265000

27.21

Ch. Srinivasa Rao

34375

0.74

K. V. Nagendra Babu

34375

0.74

 

 

 

Total

4649219

100.00

 

 

 

 

As on 11.11.2014

 

Names of Shareholders

No. of Shares

K. V. Raambabu

869657

K. Radhika

338839

K. Suresh Babu

18415

K. V. Nagendra Babu

9208

D. Gyan Prakash

9208

 

 

Total

1245327

 

 

As on 30.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

Products :

Not Available

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

Finished Goods

Countries :

v  Vietnam

v  Nigeria

 

 

Imports :

Not Available

 

 

Terms :

 

Selling :

L/C, Cash and Credit

 

 

Purchasing :

L/C, Cash and Credit

 

PRODUCTION STATUS – NOT AVAILABLE 

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

 

 

Customers :

Wholesalers, Retailers and End Users

 

 

No. of Employees :

500 (Approximately)

 

 

Bankers :

Banker Name 1

Axis Bank Limited

Branch Address

Tarnaka Branch, Secunderabad, Andhra Pradesh, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

v  State Bank of India, Nacharam I.A. Branch, Nacharam, Hyderabad - 500076,Andhra Pradesh, India

v  Axis Bank Limited, Trishul, Opposite Samartheshwar Mahadev Temple, New Law Garden, Ellisbridge, Ahmedabad – 380009, Gujarat, India

v  Punjab National Bank, Ram Nagar, Roopkee – 247667, Uttarakhand, India

 

 

Facilities :

SECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

Term loans

0.425

3.334

Corporate Loan

6.234

15.646

R and D Loan

17.175

22.443

Vehicle loan from State Bank of India

1.311

1.201

 

 

 

SHORT TERM BORROWINGS

 

 

Cash Credit from SBI – Nacharam

61.340

51.135

 

 

 

Total

86.485

93.759

 

Auditors :

 

Name :

Umesh and Krishna

Chartered Accountants

Address :

205, 2nd Floor, Lingapur House, Himayatnagar – 500029, Andhra Pradesh, India

PAN No. :

AAAFU4355N

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associates / Subsidiaries :

v  Zenova Bio Nutrition Private Limited

v  Vivo Life Science

v  Sai Pharma Distributor

v  Nanoceutica Laboratories Private Limited

 

 

CAPITAL STRUCTURE

 

After 30.09.2013

 

Authorised Capital : Rs. 65.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs. 62.266 Millions

 

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5000000

Equity Shares

Rs.10/- each

Rs.50.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4649219

Equity Shares

Rs.10/- each

Rs.46.492 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

46.492

42.266

33.812

(b) Reserves & Surplus

87.141

62.393

62.563

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

133.633

104.659

96.375

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

56.271

57.378

24.710

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

56.271

57.378

24.710

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

61.340

51.135

43.604

(b) Trade payables

40.234

33.724

29.821

(c) Other current liabilities

45.457

37.296

11.141

(d) Short-term provisions

8.059

8.487

10.744

Total Current Liabilities (4)

155.090

130.642

95.310

 

 

 

 

TOTAL

344.994

292.679

216.395

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

146.453

137.637

98.751

(ii) Intangible Assets

13.400

0.000

0.000

(iii) Capital work-in-progress

0.000

4.833

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

15.875

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

5.009

5.827

8.338

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

180.737

148.297

107.089

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

35.592

41.866

33.760

(c) Trade receivables

97.997

65.504

58.257

(d) Cash and cash equivalents

6.605

6.556

2.580

(e) Short-term loans and advances

24.063

30.456

14.709

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

164.257

144.382

109.306

 

 

 

 

TOTAL

344.994

292.679

216.395

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

 

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

480.375

423.701

369.441

 

 

Other Income

0.460

0.283

0.207

 

 

TOTAL                                    

480.835

423.984

369.648

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

135.870

121.288

105.055

 

 

Purchases of Stock-in-Trade

55.774

44.292

28.741

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

1.606

(4.905)

2.010

 

 

Employees benefits expense

93.892

80.844

56.188

 

 

Other expenses

125.892

121.515

110.155

 

 

TOTAL                                    

413.034

363.034

302.149

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

67.801

60.950

67.499

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

22.690

15.263

11.166

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

45.111

45.687

56.333

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION        

8.076

5.338

4.819

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

37.035

40.349

51.514

 

 

 

 

 

Less

TAX                                                                 

8.060

8.487

10.633

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

28.975

31.862

40.881

 

 

 

 

 

 

EARNING IN FOREIGN CURRENCY

12.863

5.106

1.312

 

 

 

 

 

 

CIF VALUE OF IMPORTS

1.769

19.844

0.000

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

6.23

6.76

11.43

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Net Profit Margin

(PAT/Sales)

(%)

6.03

7.52

11.07

 

 

 

 

 

Operating Profit Margin

(PBDIT/ Sales)

(%)

14.11

14.39

18.27

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

11.25

14.02

23.81

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.28

0.39

0.53

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.88

1.04

0.71

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.06

1.11

1.15

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

33.812

42.266

46.492

Reserves & Surplus

62.563

62.393

87.141

Net worth

96.375

104.659

133.633

 

 

 

 

long-term borrowings

24.710

57.378

56.271

Short term borrowings

43.604

51.135

61.340

Total borrowings

68.314

108.513

117.611

Debt/Equity ratio

0.709

1.037

0.880

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Revenue from operations

369.441

423.701

480.375

 

 

14.687

13.376

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Revenue from operations

369.441

423.701

480.375

Profit

40.881

31.862

28.975

 

11.07%

7.52%

6.03%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

NOTE:

 

The registered address of the company has been shifted from 4F 9, 5th Floor, Ballad Estates, Taranaka, Secunderabad – 500017, Andhra Pradesh, India to the present address w.e.f 26.02.2009

 

 

UNSECURED LOANS

 

PARTICULAR

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

Term Loans

 

 

From bank

8.927

4.241

From other financial institutions

15.683

5.040

 

 

 

Others

 

 

Deposits from C and F Agents

5.850

5.100

Deposits from Contracting Manufacture

0.548

0.255

Deposits from others

0.118

0.118

 

 

 

Total

31.126

14.754

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10177916

29/09/2011 *

125,100,000.00

STATE BANK OF INDIA

Nacharam I. A. Branch, Nacharam, Hyderabad, Andhra Pradesh - 500076, INDIA

B25494279

 

* Date of charge modification

 

 

FIXED ASSETS

 

œ  Land

œ  Factory Building

œ  Plant and Machinery

œ  Office Equipment

œ  Computer Equipment

œ  Furniture and Fixture

œ  Motor Vehicles

œ  R and D Equipment’s Factory

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.86

UK Pound

1

Rs.97.23

Euro

1

Rs.77.21

 

 

INFORMATION DETAILS

 

Information Gathered by :

HTL

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ANK

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

42

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.